Commentary: An updated review of the published studies of homocysteine and cardiovascular disease

International Journal of Epidemiology

Volumn 31, Issue 1, 2002, Pages 70-71

  Clarke, Robert ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

CARDIOVASCULAR DISEASE; HEALTH RISK;

ACCURACY; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL OBSERVATION; CLINICAL STUDY; CLINICAL TRIAL; CONCENTRATION RESPONSE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; META ANALYSIS; METHODOLOGY; NOTE; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT;

EID: 0036207857     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.1.70     Document Type: Note

References (6)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies
3. Homocyst(e)-ine and cardiovascular disease: A critical review of the epidemiologic evidence
4. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
5. Can dietary supplements with folic acid or vitamin B-6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease
6. Homocyst(e)ine and cardiovascular disease: A systematic review of the evidence with special emphasis on case-control studies and nested case-control studies